No Data
No Data
Express News | Candel Therapeutics Shares up 3.4% After FDA Grants Orphan Drug Tag for Co's Glioma Treatment
Candel Gains FDA Orphan Status for Brain Tumor Candidate
Express News | Market-Moving News for May 30th
Express News | Candel Therapeutics Shares Are Trading Higher After the FDA Granted Orphan Drug Designation to CAN-3110
Express News | Candel Therapeutics Says FDA Granted Orphan Drug Designation To Oncolytic Viral Immunotherapy CAN-3110 For Treatment Of Recurrent High-Grade Glioma
Express News | FDA Grants Orphan Drug Designation for Can-3110 for the Treatment of Recurrent High-Grade Glioma
No Data